It's time to accelerate action on rare cancers

TIME TO ACCELERATE: ACTION ON RARE CANCERS

If we focus on childhood cancer, every year in Europe, 35,000 children are diagnosed with cancer. The burden of childhood cancers in Europe constitutes the ...

It is crucial that competent authorities support awareness raising of rare cancers and establish well-identified healthcare pathways to ensure ...

ESMO's Rare Cancers Working Group Calls on the European ...

The RCWG also requests that the EU and national governments should recognise that rare adult and paediatric cancers respectively belong to both ...

Rare cancers are common: time to act - Sciendo

Rare cancer is a term based on the frequency of the disease. More specifically, the Surveillance of Rare Cancers in Europe (RARECARE) ...

Can curing rare cancers cure all cancers in one day?

Oncologist Gary Schwartz and his team at Columbia University Medical Center are investigating a cure for sarcomas, a rare cancer of ...

'Unusual' cancers emerged after pandemic. Doctors ask if covid is to ...

It's not a new idea that viruses can cause or accelerate cancer. But ... rare cancers, they have wondered about a link to the coronavirus.

Guest Blog: The Power of the Pack — New Rare Cancer Initiative ...

The cause is starting to get more attention. The U.S. government established the Rare Cancers Research Program in 2020 and has been steadily ...

Oncologists Can Help Turn the Tide Against Rare Cancers With ...

The newly launched Transformative Rare Cancer Initiative at Fred Hutch Cancer Center connects oncologists, researchers, and patients to ...

Fred Hutch launches rare cancer research effort

The biggest barrier in these cancers is the lack of interest from stakeholders. It's not possible to benefit people with rare cancers using ...

Accepting risk in the acceleration of drug development for rare cancers

Rare cancers collectively contribute a disproportionate fraction of the total burden of cancer. The oncology community is increasingly facing small numbers ...

The Burden of Rare Cancers in North America - PMC

While individual rare cancers are infrequently diagnosed, in aggregate, they account for a substantial percentage of all cancers diagnosed in the population and ...

Progress in Treating Rare Cancers | ASCO

... Rare Cancers” as the Advance of the Year ... its list of Research Priorities to accelerate progress against cancer.

ISSUE BRIEF - ASPE

We defined rare cancers as those that affect fewer than 200,000 peopleii in the United States and used the. Genetic and Rare Diseases (GARD) ...

Should rare cancers still be (in) a niche of oncology?

A new approach to rare cancers is needed to give patients better chances of benefitting from the current wave of therapeutic innovation.

Alliance for Rare Cancers (ARC) - Jed Ian Taxel Foundation

To unite the entire rare cancer community at unprecedented scale to accelerate cures for all rare cancers.

A Rare Cancer Opportunity - AACR Journals

Rare cancers significantly influence the overall cancer burden and cancer disparities. Creative community-based approaches to improve rare- ...

An Overview of Advances in Rare Cancer Diagnosis and Treatment

Although the therapeutic landscape for rare cancers is nascent, ongoing progress is evident, with treatments such as chemotherapy, surgery, transplantation, ...

Landscape of US and Global Rare Tumor Research Programs

As a result, progress has been slow for many of these cancers. While rare cancer research efforts have increased over time, the breadth of the ...

'No time to waste, no more lives to lose' says genomics pioneer. A ...

Action is needed to accelerate access and equity, especially for patients with rare cancers, who suﬀer long-term disadvantage under the current ...

Executive Summary | AACR Cancer Progress Report 2024

Thanks to the research-driven advances, more than 18 million individuals with a history of cancer were alive in the United States as of January 1, 2022, and the ...